6th Annual Drug Development Cognress- New Hot Topics Announced

6th Annual Drug Development Congress 2014

2&3 June 2014, Geneva, Switzerland

http://www.drugdevelopment-congress1.com/

 

Oxford Global are pleased to announce the return of the Pharma R&D Europe Series, the leading pharmaceutical discussion forum in Europe.

The series is made up of the following events:
•15th Annual Drug Discovery Summit
•6th Annual Drug Development Congress
•2nd Annual Discovery Chemistry & Drug Design Congress

The first round of topics have now been confirmed for the 6thAnnual Drug Development Congress, taking place on the 2nd&3rd June 2014 in Geneva, Switzerland.

Topics include:

Clinical Predictive Safety: Translational Safety and Safety Biomarkers (Including Imaging)
•Modelling and simulation for predictive clinical safety – challenges and benefits
•Examples of clinical safety modelling and simulation for decision-making in drug development
•Clinical safety biomarkers – key principles, development and qualification for clinical use
•Examples of clinical safety biomarkers in drug development incl applications of imaging

CONFIRMED SPEAKER:
Magnus Nord, Global Section Director Safety Science, AstraZeneca

Exploratory Toxicology And Mechanism Based Toxicity Testing
•Incorporation of exploratory toxicology and pathology practices (e.g. target expression profiling, GEM phenotyping, integrated pharmacology, and safety biomarkers) in drug discovery & development
•Rationale, approach, and balancing resources for achieving success in investigative toxicology studies
•Proper integration of transcriptomics, biomarkers, and tissue morphology to understand mechanism based toxicity

CONFIRMED SPEAKER:
Vito Sasseville, Executive Director, Preclinical Safety: Discovery & Investigative Safety, Novartis

Current Trends In Early Development
•Study design focusing on Adaptive Trials
•Establishing the Therapeutic Index
•Incorporating personalized ‘omics’ into early development
•Gender/ethnobridging in early drug development

CONFIRMED SPEAKER:
Pamela Garzone, Executive Director Biotechnology Clinical Research, Pfizer

Our speaker programmes have been carefully researched, ensuring delegates are exposed to the highest level of expertise. Confirmed speakers so far include:
•Pamela Garzone, Executive Director Biotechnology Clinical Research, Pfizer
•Joerg Bluemel, Director Biologics Safety Assessment, Translational Sciences, MedImmune
•Magnus Nord, Global Section Director Safety Science, AstraZeneca
•Vito Sasseville, Executive Director, Preclinical Safety: Discovery & Investigative Safety, Novartis

To find out who else will be speaking at this two-day event, visit (http://www.drugdevelopment-congress1.com/speakers/)

Register your interest today to hear over 20 outstanding case studies and presentations, across 2 interactive streams:
•Predictive Science
•Translational Medicine

Download the conference programme and view this two day event in more detail. (http://www.drugdevelopment-congress1.com/download-agenda-marketing/)

Your booking will give you free access to the 15th Annual Drug Discovery Congress and the 2nd Annual Discovery Chemistry & Drug Design Congress.

Limited discounted places are available. Contact Danielle Dalby on +44(0) 1865 248455 or email d.dalby@oxfordglobal.co.uk for more information.